Pharmaceuticals · Pharmaceuticals: Major · NSE: NGLFINE · data 2026-10-30

NGL Fine-Chem Ltd.

₹2,526-3.32% on 30 OctHealth: Strong 8.3/10

Feb 2026Low ₹2,044.7 · High ₹3,457.8+15.3%

In plain words

Price: 29.9% below its 52-week high of ₹3,602.

Delivery: 37.5% of traded shares were kept for delivery over the last 10 sessions, against 45.5% over the last 60.

A description of the data, not a recommendation.

Open full analysis — chart, results, balance sheet, red flags →

Key figures

Price

₹2,526

Market cap

₹1,606 cr

P/E

27.3

P/B

—

ROE

15.7%

ROCE

17.1%

Debt / equity

0.37

Dividend yield

0.07%

1-year return

66.0%

52-week high

₹3,602

52-week low

₹1,271

Operating margin

11.9%

Growth

Revenue (last 12 months)	₹536 cr
Net profit (last 12 months)	₹57 cr
Sales growth, 3 years (yearly)	21.7%
Profit growth, 3 years (yearly)	32.9%

Smart-money activity

5/100 · Weak over the last ~60 sessions, data 2026-10-30

Delivery vs usual 0/30: Delivery 26.9% over the last 20 sessions vs 37.9% in the 40 before (0.71x); shares delivered per day 0.44x usual; 0 delivery-spike days (3x usual shares delivered, 40%+ delivery) in the last 20 sessions.
Bulk/block deals 0/20: No bulk or block deals in the last 90 days.
Insider / SAST buys 0/15: No insider buy or SAST acquisition filings in the last 90 days. Insider sells are not collected by the site, so only buy filings count.
Mutual fund holding 0/15: No mutual fund scheme lists this stock. Latest monthly portfolios only (top 60 holdings per scheme); month-on-month change is not stored.
Accumulation evidence 0/15: No accumulation evidence row (only saved-scan stocks have one; 0 points).
Promoter pledges 5/5: No promoter pledge filings in 90 days.

A description of recorded activity (delivery, deals, insider buys, fund holding, pledges), not a recommendation. Today's most active stocks.

Story so far

● Dividend

18 Aug 26Dividend Dividend ₹1.75 (ex-date) +4.5% next session
12 Aug 25Dividend Dividend ₹1.75 (ex-date) +8.4% next session

From official exchange filings and NSE data. How the price moved after an event describes the past, not what comes next.

Common questions

Is NGL Fine-Chem Ltd. debt-free?

Its latest reported debt-to-equity ratio is 0.37.

What is NGL Fine-Chem Ltd.'s P/E ratio?

About 27.3, based on the last 12 months' earnings and a price of ₹2,526 (data 2026-10-30).

What is the 52-week high and low of NGL Fine-Chem Ltd.?

The 52-week high is ₹3,602 and the 52-week low is ₹1,271.

Similar companies

Syncom Formulation (India) Ltd. (SYNCOMF) · Windlas Biotech Ltd. (WINDLAS) · Venus Remedies Limited (VENUSREM) · Accent Microcell Limited (ACCENTMIC) · TTK Healthcare Limited (TTKHLTCARE)

The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.

Open NGLFINE in NSE Scanner →